Anaemia in the critically ill patient: Monitoring of erythropoietin therapy

BJU International

Volumn 97, Issue 6, 2006, Pages 1161-1164

  Thomas, Christian ^a   Wiesner, Christoph ^a   Melchior, Sebastian W ^a   Thüroff, Joachim W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anaemia; Diagnostic plot; Functional iron deficiency

Indexed keywords

BIOLOGICAL MARKER; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANEMIA; BLOOD CELL; BONE MARROW; CRITICAL ILLNESS; DRUG MONITORING; DRUG RESPONSE; ERYTHROPOIESIS; HUMAN; IRON DEFICIENCY; IRON METABOLISM; KIDNEY FAILURE; PRIORITY JOURNAL; RETICULOCYTE; REVIEW;

ANEMIA, IRON-DEFICIENCY; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; HEMATINICS; HUMANS; TREATMENT OUTCOME;

EID: 33745188237     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06172.x     Document Type: Review

References (15)

1. Shander A. Anemia in the critically ill. Crit Care Med 2004 20: 159 78
2. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med 2003 31 ( Suppl. 12 S651 7
3. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005 11: 14 23
4. Cavill I. Erythropoiesis and iron. Best Pract Res Clin Haematol 2002 15: 399 409
5. Napolitano LM. Scope of the problem: epidemiology of anemia and use of blood transfusions in critical care. Crit Care 2004 8 ( Suppl. 2 S1 8
6. Corwin HL. Anemia and blood transfusion in the critically ill patient: role of erythropoietin. Crit Care 2004 8 ( Suppl. 2 S42 4
7. Sowade O, Warnke H, Scigalla P et al. Avoidance of allogenic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997 89: 411 8
8. Anonymous. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001 37 ( Suppl. 1 S182 238
9. Punnonen K, Irjala K, Rajarnäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997 89: 1052 7
10. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002 48: 1066 76
11. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003 49: 1573 8
12. Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron deficiency and effectiveness of erythropoietin therapy in chronic renal failure. Am J Kidney Dis 1997 30: 532 41
13. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997 89: 4248 67
14. _ a concept for identifying different states of iron deficiency and monitoring the response to erythropoietin therapy. Med Oncol 2006 23: 23 36
15. Brugnara C, Collela GM, Cremins J et al. Effect of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994 123: 660 7